JPS55118917A - Production of quinazolone ring-containing epoxy resin - Google Patents

Production of quinazolone ring-containing epoxy resin

Info

Publication number
JPS55118917A
JPS55118917A JP2636679A JP2636679A JPS55118917A JP S55118917 A JPS55118917 A JP S55118917A JP 2636679 A JP2636679 A JP 2636679A JP 2636679 A JP2636679 A JP 2636679A JP S55118917 A JPS55118917 A JP S55118917A
Authority
JP
Japan
Prior art keywords
quinazolone
epoxy
epoxy resin
containing epoxy
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2636679A
Other languages
Japanese (ja)
Other versions
JPS6138732B2 (en
Inventor
Akira Fukami
Shohei Eto
Shigeru Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Electric Corp
Original Assignee
Mitsubishi Electric Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Electric Corp filed Critical Mitsubishi Electric Corp
Priority to JP2636679A priority Critical patent/JPS55118917A/en
Publication of JPS55118917A publication Critical patent/JPS55118917A/en
Publication of JPS6138732B2 publication Critical patent/JPS6138732B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Epoxy Resins (AREA)

Abstract

PURPOSE: To obtain the title resin capable of being compatible with a usual curing agent and forming a cured composition with ease, having improved heat resistance, by reacting a specific bisphenol compound having two quinazolone rings with an epoxy compound.
CONSTITUTION: A bisphenol compound shown by the formula (OH is substituted at o-, m-, p-position; R is bifunctional organic group) having two quinazolone rings in a molecule is reacted with an epoxy compound having two or more epoxy groups in a molecule to give a quinazolone ring-containing epoxy resin which can be cured with a curing agent having groups reative with epoxy group.
USE: Materials useful for cast, laminating, coating, etc. having improved heat resistance, mechanical and electrical properties.
COPYRIGHT: (C)1980,JPO&Japio
JP2636679A 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin Granted JPS55118917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2636679A JPS55118917A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2636679A JPS55118917A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Publications (2)

Publication Number Publication Date
JPS55118917A true JPS55118917A (en) 1980-09-12
JPS6138732B2 JPS6138732B2 (en) 1986-08-30

Family

ID=12191492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2636679A Granted JPS55118917A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Country Status (1)

Country Link
JP (1) JPS55118917A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035075A1 (en) * 2001-10-19 2003-05-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US8440677B2 (en) 2009-03-24 2013-05-14 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
US8546409B2 (en) 2009-04-20 2013-10-01 Gilead Calistoga Llc Methods of treatment for solid tumors
US8691829B2 (en) 2009-07-21 2014-04-08 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8865730B2 (en) 2012-03-05 2014-10-21 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
AU2001255667C1 (en) * 2000-04-25 2016-06-09 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10047060B2 (en) 2013-12-20 2018-08-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US10154998B2 (en) 2008-11-13 2018-12-18 Gilead Calistoga Llc Therapies for hematologic malignancies
US11021467B2 (en) 2014-06-13 2021-06-01 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
CN115044275A (en) * 2022-07-22 2022-09-13 山东佰盛能源科技有限公司 Pipeline protection coating and production process thereof

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492389B2 (en) 2000-04-25 2013-07-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US9487772B2 (en) 2000-04-25 2016-11-08 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8623881B2 (en) 2000-04-25 2014-01-07 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6949535B2 (en) 2000-04-25 2005-09-27 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US10695349B2 (en) 2000-04-25 2020-06-30 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8138195B2 (en) 2000-04-25 2012-03-20 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US10010550B2 (en) 2000-04-25 2018-07-03 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8653077B2 (en) 2000-04-25 2014-02-18 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8637533B2 (en) 2000-04-25 2014-01-28 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US10398695B2 (en) 2000-04-25 2019-09-03 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AU2001255667C1 (en) * 2000-04-25 2016-06-09 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
WO2003035075A1 (en) * 2001-10-19 2003-05-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
JP4945060B2 (en) * 2001-10-19 2012-06-06 イコス・コーポレイション Inhibition of human phosphatidylinositol 3-kinase delta
JP2005509635A (en) * 2001-10-19 2005-04-14 アイコス コーポレイション Inhibition of human phosphatidylinositol 3-kinase delta
US8779131B2 (en) 2004-05-13 2014-07-15 Icos Corporation 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
US8586597B2 (en) 2004-05-13 2013-11-19 Icos Corporation 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US9149477B2 (en) 2004-05-13 2015-10-06 Icos Corporation 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
USRE44599E1 (en) 2004-05-13 2013-11-12 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US8207153B2 (en) 2004-05-13 2012-06-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US10906907B2 (en) 2004-05-13 2021-02-02 Icos Corporation Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
USRE44638E1 (en) 2004-05-13 2013-12-10 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US10336756B2 (en) 2004-05-13 2019-07-02 Icos Corporation (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
US10154998B2 (en) 2008-11-13 2018-12-18 Gilead Calistoga Llc Therapies for hematologic malignancies
US8440677B2 (en) 2009-03-24 2013-05-14 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
US8546409B2 (en) 2009-04-20 2013-10-01 Gilead Calistoga Llc Methods of treatment for solid tumors
US8691829B2 (en) 2009-07-21 2014-04-08 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8865730B2 (en) 2012-03-05 2014-10-21 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10730879B2 (en) 2012-03-05 2020-08-04 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US9469643B2 (en) 2012-03-05 2016-10-18 Gilead Calistoga, LLC. Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10047060B2 (en) 2013-12-20 2018-08-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US10442805B2 (en) 2013-12-20 2019-10-15 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10414737B2 (en) 2013-12-20 2019-09-17 Gilead Sciences, Inc. Process methods for phosphatidylinositol 3-kinase inhibitors
US10059677B2 (en) 2013-12-20 2018-08-28 Gilead Calistoga Llc Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10954199B2 (en) 2013-12-20 2021-03-23 Gilead Sciences, Inc. Process methods for phosphatidylinositol 3-kinase inhibitors
US11021467B2 (en) 2014-06-13 2021-06-01 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
CN115044275A (en) * 2022-07-22 2022-09-13 山东佰盛能源科技有限公司 Pipeline protection coating and production process thereof

Also Published As

Publication number Publication date
JPS6138732B2 (en) 1986-08-30

Similar Documents

Publication Publication Date Title
JPS5749621A (en) Preparation of heat-resistant resin
JPS55118918A (en) Production of quinazolone ring-containing epoxy resin
JPS5723620A (en) Thermosetting resin composition
JPS5477699A (en) Heat resistant epoxy resin composition
JPS5464597A (en) Heat resistant epoxy resin composition
JPS5398400A (en) Epoxy resin composition
JPS5638319A (en) Heat-resistant resin composition
JPS5363439A (en) Covering composition and its production
JPS56127625A (en) Crosslinking agent
JPS56145919A (en) Thermosetting resin composition
JPS5728129A (en) Curing agent for epoxy resin
JPS55142023A (en) Thermosetting resin composition
JPS56115783A (en) Preparation of diisobutenylsuccinic anhydride
JPS5638318A (en) Heat-resistant resin composition
JPS5723624A (en) Epoxy resin composition
JPS5388094A (en) Preparation of curable compound
JPS5780424A (en) Thermosetting composition forming heat-resistant cured resin product
JPS54137093A (en) Preparation of modified polyarylene dicarboxylate
JPS57121026A (en) Epoxy resin composition
JPS56152831A (en) Thermosetting resin composition
JPS57170957A (en) Heat-resistant and flame-resistant resin composition
JPS5457566A (en) Heat-resistant composition for molding sliding bodies
JPS56106949A (en) Curable resin composition
JPS5571718A (en) Fast-setting epoxy resin composition
JPS5488247A (en) Borosiloxane compound and its peparation